Sacrificing the pulmonary arterial branch to the spared lobe is a risk factor of bronchopleural fistula in sleeve lobectomy after chemoradiotherapy

European Journal of Cardio-thoracic Surgery

Volumn 43, Issue 3, 2013, Pages 568-572

  Toyooka, Shinichi ^a   Soh, Junichi ^a   Shien, Kazuhiko ^a   Sugimoto, Seiichiro ^a   Yamane, Masaomi ^a   Oto, Takahiro ^a   Date, Hiroshi ^b   Miyoshi, Shinichiro ^a  

^a OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Bronchopleural fistula; Induction chemoradiotherapy; Lung cancer; Sleeve lobectomy

Indexed keywords

CISPLATIN; DOCETAXEL; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ANASTOMOSIS; ARTICLE; BRONCHOPLEURAL FISTULA; CANCER RECURRENCE; CANCER SURVIVAL; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LOBECTOMY; LUNG LOBE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PULMONARY ARTERY; RADIATION DOSE; SLEEVE LOBECTOMY;

AGED; BRONCHIAL FISTULA; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; COHORT STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLEURAL DISEASES; PNEUMONECTOMY; PULMONARY ARTERY; RECURRENCE; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84873691020     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezs323     Document Type: Article

References (18)

1. Thomas CP. Conservative resection of the bronchial tree. J R Coll Surg Edinb 1956;1:169-86.
2. Ferguson MK, Lehman AG. Sleeve lobectomy or pneumonectomy: optimal management strategy using decision analysis techniques. Ann Thorac Surg 2003;76:1782-8.
3. Deslauriers J, Gregoire J, Jacques LF, Piraux M, Guojin L, Lacasse Y. Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences. Ann Thorac Surg 2004;77: 1152-6; discussion 1156.
4. Venuta F, Ciccone AM, Anile M, Ibrahim M, De Giacomo T, Coloni GF et al. Reconstruction of the pulmonary artery for lung cancer: long-term results. J Thorac Cardiovasc Surg 2009;138:1185-91.
5. Park JS, Yang HC, Kim HK, Kim K, Shim YM, Choi YS et al. Sleeve lobectomy as an alternative procedure to pneumonectomy for non-small cell lung cancer. J Thorac Oncol 2010;5:517-20.
6. Albain KS, Swann RS, Rusch VW, Turrisi AT III, Shepherd FA, Smith C et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 2009;374:379-86.
7. Stupp R, Mayer M, Kann R, Weder W, Zouhair A, Betticher DC et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial. Lancet Oncol 2009;10:785-93.
8. Rusch VW, Giroux DJ, Kraut MJ, Crowley J, Hazuka M, Winton T et al. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol 2007;25: 313-8.
9. Kunitoh H, Kato H, Tsuboi M, Shibata T, Asamura H, Ichinose Y et al. Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806. J Clin Oncol 2008;26:644-9.
10. Yamamoto R, Tada H, Kishi A, Tojo T. Effects of preoperative chemotherapy and radiation therapy on human bronchial blood flow. J Thorac Cardiovasc Surg 2000;119:939-45.
11. Rendina EA, Venuta F, De Giacomo T, Flaishman I, Fazi P, Ricci C. Safety and efficacy of bronchovascular reconstruction after induction chemotherapy for lung cancer. J Thorac Cardiovasc Surg 1997;114:830-5; discussion 835-837.
12. Milman S, Kim AW, Warren WH, Liptay MJ, Miller C, Basu S et al. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy. Ann Thorac Surg 2009;88:945-50. discussion 950-941.
13. Katayama H, Ueoka H, Kiura K, Tabata M, Kozuki T, Tanimoto M et al. Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer. Br J Cancer 2004;90:979-84.
14. Toyooka S, Kiura K, Takemoto M, Oto T, Takigawa N, Fujiwara T et al. Long-term outcome of induction chemoradiotherapy with docetaxel and cisplatin followed by surgery for non-small-cell lung cancer with mediastinal lymph node metastasis. Interact CardioVasc Thorac Surg 2012;14:565-9.
15. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2: 706-14.
16. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55.
17. Roswit B, White DC. Severe radiation injuries of the lung. Am J Roentgenol 1977;129:127-36.
18. Davis SD, Yankelevitz DF, Henschke CI. Radiation effects on the lung: clinical features, pathology, and imaging findings. Am J Roentgenol 1992; 159:1157-64.